Preclinical evaluation of a novel engineered recombinant human anti-CD44v6 antibody for potential use in radio-immunotherapy.
about
Preclinical evaluation of a novel engineered recombinant human anti-CD44v6 antibody for potential use in radio-immunotherapy.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
Preclinical evaluation of a no ...... al use in radio-immunotherapy.
@en
Preclinical evaluation of a no ...... al use in radio-immunotherapy.
@nl
type
label
Preclinical evaluation of a no ...... al use in radio-immunotherapy.
@en
Preclinical evaluation of a no ...... al use in radio-immunotherapy.
@nl
prefLabel
Preclinical evaluation of a no ...... al use in radio-immunotherapy.
@en
Preclinical evaluation of a no ...... al use in radio-immunotherapy.
@nl
P2093
P2860
P356
P1476
Preclinical evaluation of a no ...... al use in radio-immunotherapy.
@en
P2093
Anja C Mortensen
Anna-Karin Haylock
Hans Lundqvist
Marika Nestor
P2860
P304
P356
10.3892/IJO.2018.4364
P577
2018-04-11T00:00:00Z